J.P. Morgan will pay a $200 million civil monetary penalty and desist from further violations of CFTC supervision requirements, the commission said. The civil monetary penalty could be offset by a ...

J&J acquired rights to the silicone-based drug delivery device used in TAR-200, which allows for the continuous release of medication to the bladder, when it bought privately-owned biotech Taris ...